Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis have?
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis has 460 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis published?
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis has 2022 year in the ScholarIQ index.
What is the open-access status of Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis?
Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis has hybrid oa status in the ScholarIQ index.
What is the DOI of Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis?
The DOI for Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis is on the source record.
What is the PMID of Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis?
The PMID for Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis is on the source record.
What is the OpenAlex record for Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis?
The OpenAlex for Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis is on the source record.